Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (151-160 of 208) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Research Square|January 18, 2024
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cellsJ K Wiencke, Emily Nissen, Devin C Koestler, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
NPJ Digital Medicine|August 7, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRINate Tran, Tracy L Luks, Yan Li, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology|June 15, 2023
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine gliomaSabine Mueller, Cassie Kline, Schuyler Stoller, et al.
Neuro-Oncology|October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II studyNicholas Butowski, Howard Colman, John F De Groot, et al.
Nature Communications|September 20, 2022
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survivalJ K Wiencke, Annette M Molinaro, Gayathri Warrier, et al.
Journal of the National Cancer Institute|October 1, 2021
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma SurvivalAnnette M Molinaro, John K Wiencke, Gayathri Warrier, et al.
Journal of Neurosurgery|January 14, 2023
Identification of risk factors associated with leptomeningeal disease after resection of brain metastasesRamin A Morshed, Satvir Saggi, Daniel D Cummins, et al.
Pageof 21

Showing results (151-160 of 208) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Research Square|January 18, 2024
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cellsJ K Wiencke, Emily Nissen, Devin C Koestler, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
NPJ Digital Medicine|August 7, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRINate Tran, Tracy L Luks, Yan Li, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology|June 15, 2023
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine gliomaSabine Mueller, Cassie Kline, Schuyler Stoller, et al.
Neuro-Oncology|October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II studyNicholas Butowski, Howard Colman, John F De Groot, et al.
Nature Communications|September 20, 2022
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survivalJ K Wiencke, Annette M Molinaro, Gayathri Warrier, et al.
Journal of the National Cancer Institute|October 1, 2021
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma SurvivalAnnette M Molinaro, John K Wiencke, Gayathri Warrier, et al.
Journal of Neurosurgery|January 14, 2023
Identification of risk factors associated with leptomeningeal disease after resection of brain metastasesRamin A Morshed, Satvir Saggi, Daniel D Cummins, et al.
Pageof 21